The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ERIC, RIVN and ABBV
Decision Memo Received from US Forest Service Regarding Initial Exploration Drilling at Sycamore Canyon Project, Arizona
AbbVie Inc. Investors: Last Days to Actively Participate in the Class Action Lawsuit; Portnoy Law Firm
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV
GAMERGAINS ANNOUNCES FIRST-EVER CRYPTO PLAY AND EARN PLATFORM FOR PC AND CONSOLE GAMERS WITH BACKING FROM MAJOR INVESTORS
CLASS ACTION UPDATE for ABBV, SDIG and IRNT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Seven Mortal Sins X-TASY is now available on the App Store and Google Play. Game events await players.
SHAREHOLDER ALERT: ERIC FB VRT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Albert Labs Announces the Addition of Two Renowned Scientific Advisors to its Scientific Advisory Board
Battery Mineral Resources Announces Intercept of 34 Meters of 1.35% Copper from the Cinabrio Norte Target at Its Punitaqui Copper Mine in Chile
Sierra Wireless XR Series Routers Certified by the UK's Emergency Services Network Helping to Create Safer Communities
4Front Ventures Corp. Expands Brand Portfolio and California Reach, Closes Accretive Acquisition of Island Cannabis Co.
FORTUNE BAY ANNOUNCES INITIAL DRILL TARGET AREAS AND 2022 DRILLING PLANS FOR THE STRIKE URANIUM PROJECT
AUPH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 14, 2022 in the Class Action Filed on Behalf of Aurinia Pharmaceuticals Inc. Shareholders
Foremost Lithium Intersects a New Spodumene Pegmatite and Extends Dike 8 on Its 100% Owned Zoro Lithium Project in Snow Lake, Manitoba
Mountain Province Diamonds Provides Details of First Quarter 2022 Earnings Release and Conference Call
CLASS ACTION UPDATE for AI, AUPH and LILM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Atico Produces 4.82 Million Pounds of Cu and 2,636 Ounces of Au in First Quarter 2022 and Resumes Full Operations at El Roble
TOP RANKED ROSEN LAW FIRM Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, IBM and IRNT
AUPH SHAREHOLDER ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH
Veklury® is First and Only Approved Treatment for Pediatric Patients Under 12 Years of Age with COVID-19
ABBV Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of June 6, 2022 Deadline in Securities Fraud Class Action Lawsuit
Nevada Silver Corporation Announces Changes to Private Placement Financing and Confirms DTC Eligibility
Giyani Announces Process Flowsheet Handover to Specialist Engineering Firm for Demonstration Plant Construction
SHAREHOLDER ALERT: AI GRAB ABBV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Aptose to Report First Quarter 2022 Financial Results and Hold Conference Call on Monday, May 9, 2022
Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance
Trevali Announces Mine Rehabilitation and Dewatering Progress at Perkoa Mine in Response to Flooding Event and Provides an Update on Search and Rescue Efforts
ValOre Reports High-Grade Palladium-Platinum Assays from Chromitite Outcrop Rock Samples at Tróia Target, Pedra Branca
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 at the American Society of Cataract and Refractive Surgery Annual Meeting
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced, or High-Risk Early-Stage Triple-Negative Breast Cancer